Back to FDA Applications sponsored by TAKEDA PHARMS USA

FDA Drug Application 022271 by TAKEDA PHARMS USA

Application Number022271
Application Type New Drug Application
Sponsor ApplicantTAKEDA PHARMS USA
Most Recent Label Available Flag
Current Patent Flag
Action Type Approval
Chemical Type New molecular entity (NME)
Therapeutic Potential Standard
Orphan Code 

Action TypeDuplicate CounterAction DateDocument TypeApplication Document IDSequence NumberDocument TitleDocument URLDocument Date
AP01/25/2013N35000000 1/30/2013
AP01/25/2013N35017000 1/30/2013
AP01/25/2013N35070000 2/5/2013
AP01/25/2013N35508000 3/25/2013
AP01/25/2013N35509000 3/25/2013
AP04/5/2016SE845595005,022426Orig1s003,203414Orig1s003ltr.pdf 4/7/2016
AP04/5/2016SE845617005 4/7/2016
AP08/28/2015SLR43764007,022426Orig1s005,203414Orig1s005ltr.pdf 9/1/2015
AP08/28/2015SLR43921007 9/21/2015
AP05/27/2016SLR46190009 5/31/2016
AP05/27/2016SLR46229009 6/1/2016

Back to FDA Applications sponsored by TAKEDA PHARMS USA

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer

Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.